Department of Obstetrics and Gynecology, Wakayama Medical University, School of Medicine, 811-1 Kimiidera Wakayama 641-0012, Japan.
Int J Mol Med. 2010 Jan;25(1):17-23.
We previously reported that activin A, not inhibin, was localized to endometrial tissues, and that the endometrium might be a major source of activin A during the menstrual cycle, using an immunohistochemical method. However, there are few detailed reports concerning the expression of inhibin subunits, activin receptors and Smad proteins in the ectopic endometrial tissues of endometriosis. In this study, our purpose was to evaluate the immunohistochemical localization of inhibin alpha-, betaA-subunits, activin A, activin receptor, and Smad proteins in ovarian endometriosis. Tissue samples from ovarian endometriosis were obtained from 13 women. Normal endometrial tissues were obtained during the proliferative phase from 5 premenopausal women without endometriosis who were undergoing a hysterectomy for the treatment of uterine cervical intraepithelial neoplasia 3. We examined the immunohistochemical localization of inhibin/activin alpha-, betaA-subunit, activin A, activin receptors types IA, IB, IIA, IIB, Smad2, Smad3 and Smad4 using an avidin-biotin-peroxidase complex technique. No immunostaining for the alpha-subunit of inhibin was observed in ovarian endometriosis and the normal endometrium. Positive immunostaining for the betaA-subunit of inhibin, activin A, activin receptors types IA, IB, IIA, IIB, Smad2, Smad3 and Smad4 was observed in ovarian endometriosis and the normal endometrium. In conclusion, these results suggest that activin A, but not inhibins, is produced by ovarian endometriosis and the normal endometrium, and that the activin signal transduction system exists in both ovarian endometriosis and the normal endometrium.
我们之前曾报道过,使用免疫组织化学方法,在子宫内膜组织中定位到激活素 A,而非抑制素,并且在月经周期中,子宫内膜可能是激活素 A 的主要来源。然而,关于在子宫内膜异位症的异位子宫内膜组织中抑制素亚基、激活素受体和 Smad 蛋白的表达,鲜有详细报道。在这项研究中,我们的目的是评估卵巢子宫内膜异位症中抑制素 α、βA 亚基、激活素 A、激活素受体和 Smad 蛋白的免疫组织化学定位。从 13 名女性的卵巢子宫内膜异位症组织中获得组织样本。从 5 名因宫颈上皮内瘤变 3 期而接受子宫切除术治疗的绝经前妇女的增生期子宫内膜中获得正常子宫内膜组织。我们使用亲和素-生物素-过氧化物酶复合物技术检查了抑制素/激活素 α、βA 亚基、激活素 A、激活素受体类型 IA、IB、IIA、IIB、Smad2、Smad3 和 Smad4 的免疫组织化学定位。在卵巢子宫内膜异位症和正常子宫内膜中未观察到抑制素 α 亚基的免疫染色。在卵巢子宫内膜异位症和正常子宫内膜中观察到抑制素 βA 亚基、激活素 A、激活素受体类型 IA、IB、IIA、IIB、Smad2、Smad3 和 Smad4 的阳性免疫染色。总之,这些结果表明激活素 A,而非抑制素,由卵巢子宫内膜异位症和正常子宫内膜产生,并且激活素信号转导系统存在于卵巢子宫内膜异位症和正常子宫内膜中。